EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels

Mounira Amor-Guéret

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024

DOI: 10.1016/j.bbadis.2024.167213 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Mounira Amor-Guéret. Beteiligte Einrichtung: Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France; CNRS UMR 3348, Centre Universitaire, 91405 Orsay, France; Université Paris-Sa…. Hauptthemen laut MEDLINE: Cytidine Deaminase, Carcinogenesis, Poly (ADP-Ribose) Polymerase-1. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Institut Curie, CNRS, Agence nationale de la recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytidine deaminase (CDA) is a pyrimidine salvage pathway enzyme that catalyzes the hydrolytic deamination of free cytidine and deoxycytidine to uridine and deoxyuridine, respectively. Our team discovered that CDA deficiency is associated with several aspects of genetic instability, such as increased sister chromatid exchange and ultrafine anaphase bridge frequencies. Based on these results, we sought (1) to determine how CDA deficiency contributes to genetic instability, (2) to explore the possible relationships between CDA deficiency and carcinogenesis, and (3) to develop a new anticancer treatment targeting CDA-deficient tumors. This review summarizes our major findings indicating that CDA deficiency is associated with a genetic instability that does not confer an increased cancer risk. In light of our results and published data, I propose a novel hypothesis that loss of CDA, by reducing basal PARP-1 activity and increasing Tau levels, may reflect an attempt to prevent, slow or reverse the process of carcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytidine DeaminaseCarcinogenesisPoly (ADP-Ribose) Polymerase-1HumansAnimalsNeoplasmstau ProteinsGenomic Instability

Stichwörter der Autor:innen

CancerCytidine deaminase (CDA)Genetic instabilityMicrotubule-associated protein tau (MAPT)Poly(ADP-ribose) polymerase 1(Parp-1)

Substanzen

Cytidine DeaminasePoly (ADP-Ribose) Polymerase-1tau ProteinsPARP1 protein, human

Autor:innen und Institutionen

  • Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France; CNRS UMR 3348, Centre Universitaire, 91405 Orsay, France; Université Paris-Saclay, Centre Universitaire, UMR 3348, 91405 Orsay, France. Electronic…

Förderung

  • Institut Curie
  • CNRS
  • Agence nationale de la recherche
  • Canceropole Ile-de-France
  • Ligue Nationale Contre Le Cancer
  • Fondation ARC pour la Recherche sur Le Cancer

Zitieren

APA

Amor-Guéret, M. (2024). Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167213

Vancouver

Amor-Guéret M. Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167213

BibTeX
@article{AmorGuret2024,
  author = {Amor-Guéret, Mounira},
  title = {Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2024},
  doi = {10.1016/j.bbadis.2024.167213}
}
Kostenlos starten →